查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056505

藥物傳輸市場規模、佔有率、趨勢和預測：按給藥途徑、應用、最終用戶和地區分類，2026-2034年

Pharmaceutical Drug Delivery Market Size, Share, Trends, and Forecast by Route of Administration, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年全球藥物遞送市場規模為15,333億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.46%的複合年成長率成長，到2034年達到22,988億美元。目前，北美市場佔據主導地位，預計2025年將佔42.6%的市場。推動北美市場佔有率成長的主要因素包括：對靶向高效藥物遞送系統的需求不斷成長、個人化醫療的日益普及推動了藥物遞送領域的創新，以及奈米技術的許多進步。

藥物輸送市場的發展趨勢：

對標靶治療的需求日益成長

對標靶治療日益成長的需求是藥物遞送市場的主要驅動力。傳統的全身給藥方式常常導致脫靶效應和副作用，這增加了對標靶治療和標靶藥物傳遞的需求。此外，諸如新冠肺炎 (COVID-19) 等各種危及生命的感染疾病的蔓延，促使製造商採用有效的藥物遞送裝置和技術。預計這將顯著促進未來幾年藥物遞送市場的成長。例如，2022 年 2 月，Glenmark Pharmaceuticals 在印度推出了 FabiSpray，一種用於治療重症新冠肺炎高風險成年患者的一氧化氮滴鼻劑。此外，2020 年 7 月發表在 Frontiers 上的報導指出，在糖尿病治療中，開發合適的遞送系統和針對藥物特性量身定做的綜合治療策略至關重要。報導指出，藥物遞送裝置在糖尿病治療的各個方面都展現出巨大的潛力。這些技術可以增強藥物穩定性，克服生物屏障以提高生物利用度，並作為智慧自動化系統模擬天然胰島素分泌，從而降低低血糖風險。

科技的快速發展

藥物輸送裝置和技術的持續進步，使其更加人性化、易用且精準，進一步加速了全球藥物輸送市場的成長。此外，主要市場參與者正大力投資先進藥物輸送裝置的研發與創新。例如，2021年5月，飛利浦醫療科技（Philips Medisize）推出了Aria智慧自動注射器平台，在製藥業開創了創新、差異化和永續性發展的先河。該裝置採用先進技術，例如可容納不同藥物配方和黏度的模組化藥物傳輸平台，以及可與智慧型手機、平板電腦和行動應用程式連接的內建藍牙功能。同樣，2021年6月，羅氏開發了一種使用蘭珠單抗（Lambizumab）的端口輸送系統（PDS）。這是一種藥物輸送植入，旨在使濕性老齡化黃斑部病變患者擺脫頻繁眼內注射的需要。預計這些創新和技術進步將在未來幾年推動藥物輸送市場收入的成長。

慢性病盛行率增加

全球各種慢性疾病的日益普及推高了對藥品的需求。世界衛生組織（世衛組織）指出，慢性疾病是全球首要死因。 2019年，光是缺血性心臟疾病就導致約889萬人死亡。此外，癌症、呼吸系統疾病和糖尿病在全球範圍內的日益普及也進一步推動了藥物輸送裝置的應用。根據國際癌症研究機構（IARC）2020年發布的數據，全球五分之一的人一生中會罹患癌症，八分之一的男性和十一分之一的女性會死於癌症。在女性中，乳癌、大腸癌、肺癌、子宮頸癌和甲狀腺癌較為常見。在男性中，肺癌和攝護腺癌最為常見，約佔男性所有癌症病例的三分之一。此外，根據印度國家衛生研究院2022年發布的關於慢性病盛行率及其潛在決定因素的報告，印度約有21%的老年人報告患有至少一種慢性病。慢性病病例的增加預計將推動藥物輸送市場的需求成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球藥物輸送市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依給藥途徑

  • 口服給藥
  • 注射藥物的給藥
  • 局部給藥
  • 眼科藥物輸送
  • 藥物輸送至肺部
  • 嵌入式藥物輸送系統
  • 黏膜穿透給藥
  • 鼻腔給藥

第7章 市場區隔：依應用領域分類

  • 感染疾病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系統疾病
  • 中樞神經系統疾病
  • 自體免疫疾病
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 居家醫療
  • 診斷中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112026A5796

The global pharmaceutical drug delivery market size was valued at USD 1,533.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,298.8 Billion by 2034, exhibiting a CAGR of 4.46% during 2026-2034. North America currently dominates the market, holding a significant market share of 42.6% in 2025. The rising demand for targeted and efficient drug delivery systems, increasing focus on personalized medicine fostering drug delivery innovations, and numerous advancements in nanotechnology are some of the major factors propelling the market share.

Pharmaceutical Drug Delivery Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is augmenting the demand for targeted therapies, which in turn is catalyzing the market growth. Furthermore, the rising need for personalized medication as unique genetic profiles of patients require tailored drug administration methods is also contributing to the market growth.

Key Market Trends: Numerous advancements in nanotechnology and biomaterials that facilitate precise drug delivery mechanisms, allowing for controlled release and better bioavailability, are positively influencing market growth. Moreover, the rising adoption of user-friendly drug delivery systems that can cater to the specific needs of elderly patients is also acting as another significant trend, driving the market growth.

Geographical Landscape: According to the report, North America accounted for the largest market share in the global market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases.

Competitive Landscape: Some of the leading pharmaceutical drug delivery market companies are AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A., among many others.

Challenges and Opportunities: Challenges in the global pharmaceutical drug delivery market include regulatory hurdles, complex manufacturing processes, and the need for continuous innovation. Pharmaceutical drug delivery market recent opportunities include increasing prevalence of chronic diseases, growing demand for targeted and controlled drug delivery systems, and advancements in nanotechnology and biologics.

Pharmaceutical Drug Delivery Market Trends:

Rising Demand for Targeted Therapies

The escalating demand for targeted therapies is a significant driver in the pharmaceutical drug delivery market. Traditional systemic drug administration often results in off-target effects and adverse reactions, which augment the need for targeted therapies and drug deliveries. Moreover, the growing prevalence of various life-threatening infections, such as COVID-19, is also prompting manufacturers to introduce effective drug-delivery devices and techniques. This is anticipated to significantly contribute to the pharmaceutical drug delivery market growth in the coming years. For instance, in February 2022, Glenmark Pharmaceuticals Limited launched a nitric oxide nasal spray called FabiSpray in India for the treatment of adult patients with COVID-19 who had a high risk of progression of the disease. Besides this, the article published by Frontiers in July 2020 mentioned that it is necessary to develop appropriate delivery systems and complete therapy strategies according to the nature of drugs in treating diabetes mellitus. As per the source, drug-delivery devices have shown significant potential in various aspects of diabetes treatment. They enhance the stability of drugs, overcome biological barriers to increase bioavailability, and act as a smart, automated system to mimic natural insulin delivery, reducing the risk of hypoglycemia.

Rapid Technological Advancements

Ongoing technological advancements in drug delivery devices and techniques to make them more patient-friendly, accessible, and accurate are further catalyzing the growth of the global pharmaceutical drug delivery market. In addition to this, various key market players are extensively investing in the development and innovation of advanced drug-delivery devices. For instance, in May 2021, Phillips-Medisize launched its Aria Smart Autoinjector platform, which unlocked innovation, differentiation, and sustainability in the pharmaceutical industry. This device features advanced technologies such as a modular drug delivery platform that supports a variety of drug formulations and viscosities and has built-in Bluetooth, which enables connectivity to smartphones, tablets, and mobile apps. Similarly, in June 2021, Roche developed a Port Delivery System with ranibizumab (PDS), a drug delivery implant, to free patients with wet age-related macular degeneration from the need to undergo frequent eye injections. Such innovations and technological advancements are anticipated to propel the pharmaceutical drug delivery market revenue in the coming years.

Increasing Prevalence of Chronic Diseases

The rising cases of various chronic ailments across the world are augmenting the demand for medicines and drugs. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Ischemic heart disease alone was responsible for about 8.89 million deaths in 2019. Moreover, the increasing prevalence of cancer, respiratory disease, and diabetic patients across the world is further promoting the adoption of drug delivery devices. According to the data published by the International Agency for Research on Cancer 2020, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die. Breast, colorectal, lung, cervical, and thyroid cancers are common among women. Whereas lung and prostate cancer are the most common among men, accounting for nearly one-third of all male cancers. Furthermore, according to a report published by the National Institute of Health, India, on Prevalence and Potential Determinants of Chronic Diseases, 2022, about 21% of the elderly population in India reportedly have at least one chronic disease. The escalating cases of chronic ailments are projected to bolster the pharmaceutical drug delivery market demand.

Global Pharmaceutical Drug Delivery Industry Segmentation:

This report provides an analysis of the key trends in each segment of the global pharmaceutical drug delivery market, along with forecasts at the global, regional, and country levels from 2026-2034. The market has been categorized based on the route of administration, application, end user, and region.

Breakup by Route of Administration:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Nasal Drug Delivery

Oral drug delivery represents the most popular route of administration

Pharmaceutical drug delivery market forecast indicates that oral drug delivery is a prominent route of administration where pharmaceutical compounds are ingested through the mouth and absorbed in the gastrointestinal tract. Oral medications are convenient to administer, making it a preferred choice for various medications. Moreover, the rise in R&D activities and product launches are likely to positively impact the pharmaceutical drug delivery market outlook. For instance, in June 2021, Shilpa Medicare Ltd. launched Molshil, a pediatric dose of paracetamol oral thin film, in India. Furthermore, according to the WHO, in 2021, approximately 275 million people used medications (drugs) at least once. Among them, approximately 62 million people used opioids.

Breakup by Application:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Others

Infectious diseases account for the majority of the market share

Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites, which can spread from person to person or through contaminated objects. As per the pharmaceutical drug delivery market report, the rising prevalence of infectious diseases poses significant global health challenges, necessitating effective treatment strategies. For instance, according to an article by Frontiers in February 2022, non-typhoidal Salmonella, a common cause of bacterial enteritis in humans, causes almost 93.8 million cases of gastroenteritis globally each year.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Diagnostic Centers
  • Others

As per the pharmaceutical drug delivery market overview, hospitals hold a significant share in the global market. Hospitals as primary care providers utilize a variety of drug delivery methods to ensure effective treatment for diverse patient needs. Ambulatory Surgery Centers demand specialized drug delivery techniques for perioperative care and pain management. Home Care Settings require user-friendly delivery systems for patient self-administration, promoting adherence and comfort. Diagnostic Centers rely on targeted drug delivery to enhance imaging and therapeutic interventions.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the pharmaceutical drug delivery market statistics, North America held the biggest share in the market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases. For instance, according to the American Cancer Society's 2022 report, approximately 1.9 million new cancer cases were diagnosed in 2022 in the United States. Besides this, the presence of leading manufacturers in the region, along with the introduction of new products, is also bolstering the growth of the market in North America. For instance, in February 2022, the United States FDA approved the generic Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility and other episodes associated with advanced Parkinson's disease.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • GSK plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

Key Questions Answered in This Report

1. What is pharmaceutical drug delivery?

2. How big is the pharmaceutical drug delivery market?

3. What is the expected growth rate of the global pharmaceutical drug delivery market during 2026-2034?

4. What are the key factors driving the global pharmaceutical drug delivery market?

5. What is the leading segment of the global pharmaceutical drug delivery market based on the route of administration?

6. What is the leading segment of the global pharmaceutical drug delivery market based on application?

7. What is the leading segment of the global pharmaceutical drug delivery market based on end user?

8. What are the key regions in the global pharmaceutical drug delivery market?

9. Who are the key players/companies in the global pharmaceutical drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2025
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2025
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players